Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term women. Found 61 abstracts

no pagination
Ropka ME, Keim J, Philbrick JT. Patient Decisions About Breast Cancer Chemoprevention: A Systematic Review and Meta-Analysis. Journal of Clinical Oncology. 2010 Jun;28(18):3090-5.   PMCID: PMC2903338
Sauter ER, Klein-Szanto A, MacGibbon B, Ehya H. Nipple Aspirate Fluid and Ductoscopy to Detect Breast Cancer. Diagnostic Cytopathology. 2010 Apr;38(4):244-51.   PMCID: NIHMS141667
Berg WA, Weinberg IN, Narayanan D, Lobrano ME, Ross E, Amodei L, Tafra L, Adler LP, Uddo J, Stein W, Levine EA. High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer. BREAST JOURNAL. 2006 Jul;12(4):309-23.
Bruner DW, Jones M, Buchanan D, Russo J. Reducing cancer disparities for minorities: A multidisciplinary research agenda to improve patient access to health systems, clinical trials, and effective cancer therapy. JOURNAL OF CLINICAL ONCOLOGY. 2006 May;24(14):2209-15.
Domchek SM, Friebel TM, Neuhausen SL, Wagner T, Evans G, Isaacs C, Garber JE, Daly M, Eeles R, Matloff E, Tomlinson GE, Van't Veer L, Lynch HT, Olopade O, Weber BL, Rebbeck TR. Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. LANCET ONCOLOGY. 2006 Mar;7(3):223-9.
Friedman E, Kotsopoulos J, Lubinski J, T Lynch H, Ghadirian P, Neuhausen SL, Isaacs C, Weber B, D Foulkes W, Moller P, Rosen B, Kim-Sing C, Gershoni-Baruch R, Ainsworth P, Daly M, Tung N, Eisen A, Olopade OI, Karlan B, Saal HM, Garber JE, Rennert G, Gilchrist D, Eng C, Offit K, Osborne M, Sun P, Narod SA. Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers. BREAST CANCER RESEARCH. 2006 Jan;8(2):Art.
Gronwald J, Tung N, Foulkes WD, Offit K, Gershoni R, Daly M, Kim-Sing C, Olsson H, Ainsworth P, Eisen A, Saal H, Friedman E, Olopade O, Osborne M, Weitzel J, Lynch H, Ghadirian P, Lubinski J, Sun P, Narod SA. Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. International journal of cancer. 2006 May;118(9):2281-4.
Manne SL, Ostroff JS, Norton TR, Fox K, Goldstein L, Grana G. Cancer-related relationship communication in couples coping with early stage breast cancer. PSYCHO-ONCOLOGY. 2006 Mar;15(3):234-47.
McGuire V, John EM, Felberg A, Haile RW, Boyd NF, Thomas DC, Jenkins MA, Milne RL, Daly MB, Ward J, Terry MB, Andrulis IL, Knight JA, Godwin AK, Giles GG, Southey M, West DW, Hopper JL, Whittemore AS. No increased risk of breast cancer associated with alcohol consumption among carriers of BRCA1 and BRCA2 mutations ages < 50 years. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2006 Aug;15(8):1565-7.
Fernandez SV, Russo IH, Lareef M, Balsara B, Russo J. Comparative genomic hybridization of human breast epithelial cells transformed by estrogen and its metabolites. International Journal of Oncology. 2005 Mar;26(3):691-5.
Kell MR, Morrow M. An adequate margin of excision in ductal carcinoma in situ - 2 mm plus radiotherapy is as good as a bigger margin. British Medical Journal. 2005 Oct 08;331(7520):789-90.
Russo J, Mailo D, Hu YF, Balogh G, Sheriff F, Russo IH. Breast differentiation and its implication in cancer prevention. Clinical Cancer Research. 2005 Jan 15;11(2):931S-936S.
Katz ML, Ruzek SB, Miller SM, Legos P. Gender differences in patients needs and concerns to diagnostic tests for possible cancer. Journal of Cancer Education. 2004 Jan;19(4):227-31.
Manne S, Fasanella N, Connors J, Floyd B, Wang H, Lessin S. Sun protection and skin surveillance practices among relatives of patients with malignant melanoma: prevalence and predictors. Prev Med. 2004 Jul;39(1):36-47.
Sauter ER, Klein-Szanto A, Ehya H, MacGibbon B. Ductoscopic cytology and image analysis to detect breast carcinoma. Cancer. 2004 Sep 15;101(6):1283-92.
Wallace SG, Goldstein LJ. Nonepithelial malignancies of the breast - The Chugh/Baker article reviewed. ONCOLOGY-NEW YORK. 2004 May;18(5):675-6.
Whittemore AS, Balise RR, Pharoah PD, DiCioccio RA, Oakley-Girvan I, Ramus SJ, Daly M, Usinowicz MB, Garlinghouse-Jones K, Ponder BA, Buys S, Senie R, Andrulis I, John E, Hopper JL, Piver MS. Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations. British Journal of Cancer. 2004 Nov 29;91(11):1911-5.
Fang CY, Miller SM, Daly MB, Hurley K. The influence of attentional style and risk perceptions on intentions to undergo prophylactic oophorectomy among first- degree relatives. Psychology & Health. 2002 Jun;17(3):365-76.
Daly M. NCCN practice guidelines: Genetics/familial high-risk cancer screening. Oncology-New York. 1999 Nov;13(11A):161-82.
Fowble B, Hanlon A, Freedman G, Patchefsky A, Kessler H, Nicolaou N, Hoffman J, Sigurdson E, Boraas M, Goldstein L. Postmenopausal hormone replacement therapy: Effect on diagnosis and outcome in early-stage invasive breast cancer treated with conservative surgery and radiation. Journal of Clinical Oncology. 1999 Jun;17(6):1680-8.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term women

women Oncology risk ovarian-cancer cancer tamoxifen breast cancer surgery biopsy mutation carriers oophorectomy prevention history prostate nipple aspirate fluid families analysis psychological distress discharge fiberoptic ductoscopy BRCA2 mammography carcinoma brca1 markers BRCA1 residual cancer positron emission tomography risk reduction distinct regions breast-cancer sunscreen use clinical-experience estrogen-receptor modulators hereditary breast-cancer Psychology hodgkins-disease hereditary breast care information unknown susceptibility genes colorectal-cancer distress communication myocardial-infarction genetic epidemiology prophylactic bias community estrogen-receptor status ovarian cancer prophylactic mastectomy contralateral breast familial breast breast- mammary ductoscopy prophylactic oophorectomy patterns coping style li-fraumeni-syndrome perceptions self-examination carcinogenesis estrogen morbidity preoperative assessment cowden-syndrome physical impairment coronary heart-disease acceptance genetic-heterogeneity radiation-therapy ovarian cancer oral contraceptives prostate-cancer support marital satisfaction quality-of-life mortality transformation cutaneous melanoma ductal lavage breast-cancer risk epithelial-cells cancer prevention familial-ovarian-cancer Environmental & Occupational Health Public issues birth tissue decision- raloxifene therapy steroid-receptors wives cancer risk cytology Multidisciplinary Psychology american society recruitment strategies allelic loss african-americans noncarriers breast cancer detection age retention exfoliative cytology increased risk primary peritoneal carcinoma CGH Biomedical Social Sciences hormone-replacement therapy brachytherapy colposcopy quantitative-analysis breast susceptibility genes health beliefs radiotherapy cardiovascular-disease tumor bed participation perceived benefits image analysis breast ductoscopy-cytology-breast carcinoma directions conflict partners barriers fluorodeoxyglucose lipids image positron emission mammography prospective cohort estrogen-progestogen replacement surgical-management management radiation mastectomy strategies quality 2-OH-E-2 trial resonance acute perceived risk germline mutations cell transformation monitoring efficacy mri relationship communication
Last updated on Saturday, August 15, 2020